The post traumatic stress disorder (PTSD) market was valued at USD 1.87 Billion in 2025 and is expected to grow at a CAGR of 4.20%, reaching USD 2.82 Billion by 2035. The growth is supported by rising prevalence of PTSD and increased accessibility to pharmacological and therapeutic interventions.
Base Year
Historical Period
Forecast Period
The increasing cases of post traumatic stress disorder, particularly among military personnel, first responders, and trauma survivors, is driving the demand for effective treatments.
Increased clinical research and the rise in strategic partnerships among the leading pharmaceutical companies are major market trends.
The rising introduction of novel drugs, the growth in telehealth services and online support groups, and the increasing investment in PTSD research are anticipated to elevate the market value in the forecast period.
Compound Annual Growth Rate
4.2%
Value in USD Billion
2026-2035
*this image is indicative*
Post traumatic stress disorder (PTSD) is a mental health condition that can develop after experiencing a terrifying event. Common symptoms include flashbacks/nightmares of similar situations, severe anxiety, uncontrollable thoughts about the event, memory lapses, distorted sense of self, hyperarousal, unexplained upset stomach, and sleep disturbances, among others.
The growing demand for effective treatments is expected to stimulate research initiatives focused on understanding and addressing PTSD, creating a positive feedback loop that would further aid the growth of post traumatic stress disorder (PTSD) market. The increased dedication of researchers toward finding effective PTSD treatments is evident in various studies, exemplified by recent research results. The conclusive findings of such studies are contributing to the growing body of knowledge surrounding PTSD, fostering a deeper understanding of the condition. The rigorous efforts of the research community, coupled with the introduction of innovative therapies, are instrumental in shaping the trajectory of the PTSD market, promising a future marked by increased awareness, advanced treatment options, and sustained growth within the healthcare landscape.
Increasing Prevalence of Post Traumatic Stress Disorder Drives Market Growth
The prevalence of post traumatic stress disorder (PTSD) is on the rise and is significantly driving the market growth. Increasing stress and adapting to a sedentary lifestyle are the main factors that trigger the occurrence of PTSD in people. According to the National Center for PTSD, 6 out of 10 men (or 60%) and 5 of every 10 women (or 50%) experience at least one trauma in their lifetime. Thus, the increasing cases of post traumatic stress disorder, particularly among military personnel, first responders, and trauma survivors, is a primary driver of the market.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
“Post Traumatic Stress Disorder (PTSD) Market Report and Forecast 2026-2035” offers a detailed analysis of the market based on the following segments:
Market Breakup by Drug Class
Market Breakup by Route of Administration
Market Breakup by Age Group
Market Breakup by End User
Market Breakup by Region
Drug Class Segment is Anticipated to Witness Substantial Growth
Based on the drug class, the market is segmented into antidepressants, antipsychotics, anti-anxiety drugs, and others. Antidepressants, including SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors), are the commonly prescribed medications for post traumatic stress disorder owing to their high efficacy and better tolerability. The rising focus on R&D activities to improve existing formulations and develop new antidepressants with fewer side effects is projected to aid the growth of this segment.
The market segmentation by region includes the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. The United States represents one of the largest markets for post traumatic stress disorder owing to the significant prevalence of this mental condition, a well-established healthcare system, and a growing focus on mental health awareness. The market also benefits from the rising adoption of telehealth platforms in the region, which allows greater access to mental health services. Moreover, increased campaigns aimed at destigmatizing PTSD and substantial funding for mental health treatments are poised to boost the market growth.
The key features of the market report comprise patent analysis, grants analysis, clinical trial analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:
Pfizer is one of the leading companies in the market and holds an extensive portfolio in mental health treatment. The company's popular drug Zoloft (sertraline hydrochloride) is widely used to help manage symptoms of anxiety and depression associated with PTSD.
Headquartered in Indianapolis, Indiana, Eli Lilly and Company has a prominent presence in the market. The company invests heavily in clinical trials to validate new therapeutic options for PTSD patients.
Janssen (the pharmaceutical division of Johnson & Johnson) plays a significant role in the growth of the market for post traumatic stress disorder. The company is known for its antipsychotic medications and is also engaged in researching other pharmacological options for the treatment of PTSD.
GSK plc, headquartered in Brentford, United Kingdom, is a leading player in the market. GSK's portfolio includes various antidepressants that help in managing PTSD symptoms.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company, Bristol-Myers Squibb Company, H. Lundbeck A/S, Genentech USA, Inc., and Eisai Co., Ltd., among others.
Upto 15% Off
USD
$5499 $4949
$3299 $2969
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Class |
|
| Breakup by Route of Administration |
|
| Breakup by Age Group |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share